Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 735

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy

Liu, Yao, Xun, Zhenzhen, Ma, Kun, Liang, Shuhang, Li, Xianying, Zhou, Shuo, Sun, Linmao, Liu, Yufeng, Du, Yanhua, Guo, Xinyu, Cui, Tianming, Zhou, Huanran, Wang, Jizhou, Yin, Dalong, Song, Ruipeng, Zhang, Shugeng, Cai, Wei, Meng, Fanzheng, Guo, Hongrui, Zhang, Bo, Yang, Di, Bao, Rujuan, Hu, Qingsong, Wang, Jiabei, Ye, Youqiong, Liu, Lianxin·2023·Journal of Hepatology

Abstract

BACKGROUND & AIMS The tumour microenvironment (TME) is a crucial mediator of cancer progression and therapeutic outcome. The TME subtype correlates with patient response to immunotherapy in multiple cancers. Most of the previous studies focused on the role of different cellular components in the TME associated with immunotherapy efficacy. However, the specific structure of the TME and its role in immunotherapy efficacy remain largely unknown. METHODS We combined spatial transcriptomics (ST) with single-cell RNA sequencing (scRNA-seq) and multiplexed immunofluorescence of anti-PD-1-treated hepatocellular carcinoma (HCC) patients to reveal specific spatial structures in the TME related to immunotherapy efficacy. RESULTS We revealed the tumour immune barrier (TIB) structure, a spatial niche composed of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) located near the tumour boundary, which is associated with the efficacy of immune checkpoint blockade (ICB) treatment. Furthermore, we dissected ligand‒receptor networks among malignant cells, SPP1+ macrophages, and CAFs; that is, the hypoxic microenvironment promotes SPP1 expression, and SPP1+ macrophages interact with CAFs to stimulate extracellular matrix remodelling and promote TIB structure formation, thereby limiting immune infiltration in the tumour core. Preclinically, the blockade of SPP1 or macrophage-specific deletion of Spp1 in mice led to enhanced efficacy of anti-PD-1 treatment in mouse liver cancer accompanied by reduced CAF infiltration and increased cytotoxic T-cell infiltration. CONCLUSIONS We identified that the TIB structure formed by the interaction of SPP1+ macrophages and CAFs is related to immunotherapy efficacy. Therefore, disruption of the TIB structure by blocking SPP1 may be considered a relevant therapeutic approach to enhance the therapeutic effect of ICB treatment in HCC. IMPACT AND IMPLICATIONS Only a limited number of patients with HCC benefit from tumour immunotherapy, which significantly hinders the application of immunotherapy in HCC patients. Here, we used multiomics to identify the spatial structure of the tumour immune barrier (TIB), which is formed by the interaction of SPP1+ macrophages and CAFs in the HCC microenvironment and contributes to immunotherapy efficacy by limiting immune cell infiltration into malignant regions. Preclinically, we revealed that blocking SPP1 or macrophage-specific deletion of Spp1 in mice could destroy the TIB structure and sensitize HCC cells to immunotherapy. These results provide the first key steps towards finding more effective therapies for HCC and have a strong impact on physicians, scientists, and drug developers in the field of HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2023.01.011

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 735

Metadata

Authors
Liu, Y., Xun, Z., Ma, K., Liang, S., Li, X., Zhou, S., Sun, L., Liu, Y., Du, Y., Guo, X., Cui, T., Zhou, H., Wang, J., Yin, D., Song, R., Zhang, S., Cai, W., Meng, F., Guo, H., Zhang, B., Yang, D., Bao, R., Hu, Q., Wang, J., Ye, Y., & Liu, L.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2023-04
Volume
78
Issue
4
Pages
770-782
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4318197608
Cited by
735
References
36
FWCI
76.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. https://app.cochat.ai/papers/10.1016/j.jhep.2023.01.011
The paper
Liu, Y., Xun, Z., Ma, K., Liang, S., Li, X., Zhou, S., Sun, L., Liu, Y., Du, Y., Guo, X., Cui, T., Zhou, H., Wang, J., Yin, D., Song, R., Zhang, S., Cai, W., Meng, F., Guo, H., . . . Liu, L. (2023). Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2023.01.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.